BioCentury
ARTICLE | Company News

Alkermes, Recro deal

April 13, 2015 7:00 AM UTC

Recro Pharma will purchase from Alkermes IV/IM meloxicam and its related business unit and manufacturing facility in Gainesville, Georgia. The manufacturing facility employs about 165 people and produces four drugs for third-party pharmaceutical companies. IV/IM meloxicam, a cyclooxygenase-2 (COX-2) inhibitor NSAID developed using Alkermes’ NanoCrystal technology, has completed Phase II testing to treat moderate to severe acute pain. ...